226 related articles for article (PubMed ID: 8666924)
1. Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression.
Mohapatra S; Yang X; Wright JA; Turley EA; Greenberg AH
J Exp Med; 1996 Apr; 183(4):1663-8. PubMed ID: 8666924
[TBL] [Abstract][Full Text] [Related]
2. Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and gamma-adducin.
Matou-Nasri S; Gaffney J; Kumar S; Slevin M
Int J Oncol; 2009 Oct; 35(4):761-73. PubMed ID: 19724912
[TBL] [Abstract][Full Text] [Related]
3. Krüppel-like factor 5 promotes mitosis by activating the cyclin B1/Cdc2 complex during oncogenic Ras-mediated transformation.
Nandan MO; Chanchevalap S; Dalton WB; Yang VW
FEBS Lett; 2005 Aug; 579(21):4757-62. PubMed ID: 16102754
[TBL] [Abstract][Full Text] [Related]
4. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage.
Jin P; Hardy S; Morgan DO
J Cell Biol; 1998 May; 141(4):875-85. PubMed ID: 9585407
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain.
Vincent I; Jicha G; Rosado M; Dickson DW
J Neurosci; 1997 May; 17(10):3588-98. PubMed ID: 9133382
[TBL] [Abstract][Full Text] [Related]
6. RHAMM/hyaluronan inhibit β-catenin degradation, enhance downstream signaling, and facilitate fibrosarcoma cell growth.
Berdiaki A; Thrapsanioti LN; Giatagana EM; K Karamanos N; C Savani R; N Tzanakakis G; Nikitovic D
Mol Biol Rep; 2023 Nov; 50(11):8937-8947. PubMed ID: 37710072
[TBL] [Abstract][Full Text] [Related]
7. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest.
Park M; Chae HD; Yun J; Jung M; Kim YS; Kim SH; Han MH; Shin DY
Cancer Res; 2000 Feb; 60(3):542-5. PubMed ID: 10676633
[TBL] [Abstract][Full Text] [Related]
8. Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses.
Kawamoto H; Koizumi H; Uchikoshi T
Am J Pathol; 1997 Jan; 150(1):15-23. PubMed ID: 9006317
[TBL] [Abstract][Full Text] [Related]
9. Transient suppression of nuclear Cdc2 activity in response to ionizing radiation.
Kim MJ; Lee JY; Lee SJ
Oncol Rep; 2008 May; 19(5):1323-9. PubMed ID: 18425394
[TBL] [Abstract][Full Text] [Related]
10. Immortal, non-tumourigenic mouse mammary outgrowths express high levels of cyclin B1 and activation of cyclin B1/cdc2 kinase.
Said TK; Bonnette S; Medina D
Cell Prolif; 1996 Nov; 29(11):623-39. PubMed ID: 9105418
[TBL] [Abstract][Full Text] [Related]
11. The Receptor for Hyaluronan-Mediated Motility (CD168) promotes inflammation and fibrosis after acute lung injury.
Cui Z; Liao J; Cheong N; Longoria C; Cao G; DeLisser HM; Savani RC
Matrix Biol; 2019 May; 78-79():255-271. PubMed ID: 30098420
[TBL] [Abstract][Full Text] [Related]
12. Geldanamycin induces G2 arrest in U87MG glioblastoma cells through downregulation of Cdc2 and cyclin B1.
Nomura N; Nomura M; Newcomb EW; Zagzag D
Biochem Pharmacol; 2007 May; 73(10):1528-36. PubMed ID: 17324379
[TBL] [Abstract][Full Text] [Related]
13. Centrosomal and cytoplasmic Cdc2/cyclin B1 activation precedes nuclear mitotic events.
De Souza CP; Ellem KA; Gabrielli BG
Exp Cell Res; 2000 May; 257(1):11-21. PubMed ID: 10854050
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 2 (TLR2), transforming growth factor-β, hyaluronan (HA), and receptor for HA-mediated motility (RHAMM) are required for surfactant protein A-stimulated macrophage chemotaxis.
Foley JP; Lam D; Jiang H; Liao J; Cheong N; McDevitt TM; Zaman A; Wright JR; Savani RC
J Biol Chem; 2012 Oct; 287(44):37406-19. PubMed ID: 22948158
[TBL] [Abstract][Full Text] [Related]
15. The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.
Niedworok C; Kretschmer I; Röck K; Vom Dorp F; Szarvas T; Heß J; Freudenberger T; Melchior-Becker A; Rübben H; Fischer JW
PLoS One; 2013; 8(9):e75681. PubMed ID: 24069434
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of receptor for hyaluronan-mediated motility (RHAMM) in MC3T3-E1 cells induces proliferation and differentiation through phosphorylation of ERK1/2.
Hatano H; Shigeishi H; Kudo Y; Higashikawa K; Tobiume K; Takata T; Kamata N
J Bone Miner Metab; 2012 May; 30(3):293-303. PubMed ID: 21947782
[TBL] [Abstract][Full Text] [Related]
17. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid, CD44 and RHAMM regulate myoblast behavior during embryogenesis.
Leng Y; Abdullah A; Wendt MK; Calve S
Matrix Biol; 2019 May; 78-79():236-254. PubMed ID: 30130585
[TBL] [Abstract][Full Text] [Related]
19. p53 regulates a G2 checkpoint through cyclin B1.
Innocente SA; Abrahamson JL; Cogswell JP; Lee JM
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2147-52. PubMed ID: 10051609
[TBL] [Abstract][Full Text] [Related]
20. Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells.
Jin P; Gu Y; Morgan DO
J Cell Biol; 1996 Aug; 134(4):963-70. PubMed ID: 8769420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]